Literature DB >> 2899395

Placental transfer of beta-adrenergic antagonists studied in an in vitro perfusion system of human placental tissue.

H Schneider1, M Proegler.   

Abstract

Maternofetal transfer of five beta-blockers differing in molecular weight, solubility, and binding to albumin was studied using a dual in vitro perfusion system of an isolated cotyledon of human placenta. At steady state the diffusion rate of the lipid-soluble propranolol, timolol, and labetalol was three to four times higher than that of the hydrophilic atenolol and celiprolol. Albumin binding had no significant effect on diffusion when equal concentrations were used in the two perfusion circuits. With increased albumin concentration on the fetal side an acceleration of the diffusion of propranolol could be shown. Propranolol and labetalol showed considerable binding to placental tissue. After bolus injection transfer was clearly suppressed, as a result of tissue binding, and there was a delay until a steady state of diffusion was reached when constant concentrations were maintained in the maternal compartment. With recirculation of the fetal and maternal compartments propranolol rapidly equilibrated in the two perfusion circuits at 35% of the initial level in the maternal circuit. Atenolol after 4 hours of recirculation had not reached full equilibration between the two compartments, and the fetal concentration was at 55% of the initial level on the maternal side.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2899395     DOI: 10.1016/0002-9378(88)90491-7

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  7 in total

1.  Placental transfer of theophylline in an in vitro closed perfusion system of human placenta isolated lobule.

Authors:  D Omarini; M M Barzago; A Bortolotti; G Lucchini; F Stellari; S Efrati; M Bonati
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1993 Oct-Dec       Impact factor: 2.441

Review 2.  Celiprolol. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in cardiovascular disease.

Authors:  R J Milne; M M Buckley
Journal:  Drugs       Date:  1991-06       Impact factor: 9.546

Review 3.  Effects of antihypertensive drugs on the unborn child: what is known, and how should this influence prescribing?

Authors:  S M Khedun; B Maharaj; J Moodley
Journal:  Paediatr Drugs       Date:  2000 Nov-Dec       Impact factor: 3.022

4.  Studies on placental transfer of celiprolol.

Authors:  B Kofahl; D Henke; A Hettenbach; E Mutschler
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

5.  Investigating the effect of cholinergic and adrenergic blocking agents on maternal-fetal heart rates and their interactions in mice fetuses.

Authors:  Ahsan H Khandoker; Maisam Wahbah; Chihiro Yoshida; Yoshiyuki Kasahara; Kiyoe Funamoto; Kyuichi Niizeki; Yoshitaka Kimura
Journal:  Biol Open       Date:  2022-04-13       Impact factor: 2.643

Review 6.  The Risk for Neonatal Hypoglycemia and Bradycardia after Beta-Blocker Use during Pregnancy or Lactation: A Systematic Review and Meta-Analysis.

Authors:  Rosalie de Bruin; Sarah L van Dalen; Shamaya J Franx; Viraraghavan V Ramaswamy; Sinno H P Simons; Robert B Flint; Gerbrich E van den Bosch
Journal:  Int J Environ Res Public Health       Date:  2022-08-04       Impact factor: 4.614

Review 7.  Pharmacokinetics of the most commonly used antihypertensive drugs throughout pregnancy methyldopa, labetalol, and nifedipine: a systematic review.

Authors:  Dylan van de Vusse; Paola Mian; Sam Schoenmakers; Robert B Flint; Willy Visser; Karel Allegaert; Jorie Versmissen
Journal:  Eur J Clin Pharmacol       Date:  2022-09-15       Impact factor: 3.064

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.